EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Faecal microbiota transplant for Parkinson’s disease: promises and future directions

Eng King Tan, Jia Dong James Wang iD, Sven Pettersson, Qing Wang iD, Ryosuke Takahashi iD, Werner Poewe, Joseph Jankovic, Olivier Rascol

Brain · 08.01.2026 · 149 (1) · 59-70

DOI: 10.1093/brain/awaf419 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain, online erschienen am 05.11.2025. Verfasst von Eng King Tan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Neuroscience Institute, Duke NUS Medical School, 169857, Singapore. Hauptthemen laut MEDLINE: Parkinson Disease, Fecal Microbiota Transplantation, Gastrointestinal Microbiome. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Medical Research council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is considerable evidence linking alterations in gut microbiome composition with Parkinson’s disease, leading to several recent randomized controlled faecal microbiota transplantation (FMT) trials in patients with Parkinson’s disease targeting gut dysbiosis with the aim to modulate the gut–brain axis. Some FMT trials have observed motor and non-motor symptoms improvements in patients with Parkinson’s disease, possibly through microbiota linked enhanced short-chain fatty acid or other metabolite effects and reduced systemic inflammation. While the findings are exciting and can potentially open a new treatment paradigm, crital questions on donor selection, the optimal screening and selection of the donor microbiome, delivery routes and the timing and frequency of transplantation need to be addressed. We suggest that future FMT trials should incorporate blood, metabolites, urine and functional neuroimaging biological markers and to control for dietary, lifestyle comorbidities, medication intake and/or other potential variables to ensure optimal evaluation of interactions between the gut microbes and brain outcomes prospectively over a longer time frame.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseFecal Microbiota TransplantationGastrointestinal MicrobiomeHumansDysbiosis

Stichwörter der Autor:innen

Parkinson’s diseasedysbiosisfaecal microbiota transplantgut–brain axisneurodegenerative disordersneuroinflammation

Autor:innen und Institutionen

  • Department of Neurology, National Neuroscience Institute, Duke NUS Medical School, 169857, Singapore.
  • Department of Dental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • School of Medical and Life Sciences, Sunway University, Sunway City 47500, Malaysia.
  • Department of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong 510282, People's Republic of China.
  • Department of Neurology, Kyoto University, Kyoto 606-8501, Japan.
  • Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

ORCID-Profile: Jia Dong James Wang, Qing Wang, Ryosuke Takahashi

Förderung

  • National Medical Research council

Zitieren

APA

Tan, E. K., Wang, J. D. J., Pettersson, S., Wang, Q., Takahashi, R., Poewe, W., Jankovic, J., & Rascol, O. (2026). Faecal microbiota transplant for Parkinson’s disease: promises and future directions. Brain, 149(1), 59-70. https://doi.org/10.1093/brain/awaf419

Vancouver

Tan EK, Wang JDJ, Pettersson S, Wang Q, Takahashi R, Poewe W, et al. Faecal microbiota transplant for Parkinson’s disease: promises and future directions. Brain. 2026;149(1):59-70. doi:10.1093/brain/awaf419

BibTeX
@article{Tan2026,
  author = {Tan, Eng King and Wang, Jia Dong James and Pettersson, Sven and Wang, Qing and Takahashi, Ryosuke and Poewe, Werner and Jankovic, Joseph and Rascol, Olivier},
  title = {Faecal microbiota transplant for Parkinson’s disease: promises and future directions},
  journal = {Brain},
  year = {2026},
  volume = {149},
  number = {1},
  pages = {59--70},
  doi = {10.1093/brain/awaf419}
}
Kostenlos starten →